The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes
Author:
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 119 (2) , 160-167
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Persistent Atrial Fibrillation Is Associated With Reduced Risk of Torsades de Pointes in Patients With Drug-Induced Long QT SyndromeJACC, 2008
- Relevance of anaesthesia for dofetilide-induced torsades de pointes in α1 -adrenoceptor-stimulated rabbitsBritish Journal of Pharmacology, 2008
- Potentiation of E‐4031‐induced torsade de pointes by HMR1556 or ATX‐II is not predicted by action potential short‐term variability or triangulationBritish Journal of Pharmacology, 2007
- Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointesEP Europace, 2007
- Combined pharmacological block of IKr and IKs increases short‐term QT interval variability and provokes torsades de pointesBritish Journal of Pharmacology, 2007
- Does Tpeak–Tend provide an index of transmural dispersion of repolarization?Heart Rhythm, 2007
- Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointesBritish Journal of Pharmacology, 2002
- Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trialAmerican Heart Journal, 1999
- Torsades de pointes with Almokalant, a new class III antiarrhythmic drugAmerican Heart Journal, 1993
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990